Report of Foreign Issuer (6-k)
March 22 2018 - 8:06AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of:
March 2018
Commission file number:
333-209744
TODOS
MEDICAL LTD.
(Translation of registrant's name into English)
1 Hamada Street
Rehovot, Israel
+972-8-633-3964
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F
x
Form 40-F
¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1):
¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7):
¨
This Report of Foreign Private Issuer on Form 6-K of the Registrant
consists of the press release issued by the Registrant on March 22, 2018, entitled “Todos Medical reports on results of clinical
trials for its blood test for breast cancer screening (TM - B1) conducted at Kaplan Hospital in Rehovot, Israel”, which is
attached hereto as Exhibit 99.1.
Exhibit No.
|
99.1
|
Press
Release issued by Todos Medical Ltd. on March 22, 2018
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
TODOS MEDICAL LTD.
(Registrant)
|
|
|
By /s/ Rami Zigdon
|
|
|
Name: Rami Zigdon
|
|
|
Title: Chief Executive Officer
|
|
Date: March 22, 2018
Todos Med (CE) (USOTC:TOMDF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Todos Med (CE) (USOTC:TOMDF)
Historical Stock Chart
From Apr 2023 to Apr 2024